Why BGPT?
logo

Review Against the Reported Record

Check a paper's claims against linked experiments, exact results, stated scope, and limitations.Know what falsifiable science actually supports before you trust the answer.

Press Enter ↡ to search evidence


     Long Explanation



    Evidence for the Four-State Model

    Neftel et al. profiled 28 glioblastomas (20 adult, 8 pediatric) with SMART-Seq2, yielding 24,131 profiled cells of which 7,930 passed quality control (~5,730 genes/cell), plus a 10x Genomics validation set of 16,201 cells from 9 tumors and 401 TCGA bulk samples. They converged intra-tumoral variability on six meta-modules (39–50 genes each) defining NPC-like, OPC-like, AC-like, and MES-like malignant states, with MES1/MES2 and NPC1/NPC2 subprograms .

    The decisive mechanistic findings: each tumor contains β‰₯2 states; 15% of cells are hybrids; 37 CNA-defined subclones across 12 tumors each contained multiple states (same-state pairs 51% within vs 46% across subclones), arguing genetic subclones do not dictate states. EGFR amplification associated with AC-like, PDGFRA with OPC-like, CDK4 with NPC-like (all p<10βˆ’5 in TCGA), and 5q loss/NF1 with MES-like states . Functional validation: EGFR overexpression drove AC-like programs and GFAP+ induction in mouse NPCs; CDK4 drove NPC-like programs and NPC proliferation (p<0.0001). Barcoded lineage tracing showed 39% of multi-cell barcodes spanning multiple states, and single barcodes giving rise to all four statesβ€”direct in vivo evidence of plasticity .

    Critical Appraisal and Blindspots

    Strengths: Multiple orthogonal validations (RNA-ISH in 10 specimens, cross-platform 10x replication, mouse models, human PDXs, TCGA bulk integration) and open data (SCP393, GSE131928). Limitations the authors partially acknowledge: CNA inference from scRNA-seq misses small events; barcoded mouse models may not recapitulate human biology; microenvironment influences incompletely captured .

    Independent follow-up qualifies the model: GLICO cerebral organoid experiments confirmed that microenvironment is necessary to maintain primary-tumor state distributions—purely cell-intrinsic plasticity is not the whole story . A 2025 preprint extended the framework clinically: drug-induced reversible state shifts (panobinostat→MES-like) drive resistance, and state-selective lethality combinations (panobinostat+paxalisib, CI<1) exploit the plasticity Neftel described .

    Remaining gaps: No direct causal test that manipulating EGFR/CDK4/PDGFRA in vivo shifts the steady-state distribution; MES-like state had no significant CNA association in TCGA amplification analysis (only 5q loss/NF1 associations); temporal evolution of states during therapy (Stupp regimen) untested; cell-state assignments from ~400-gene signatures may conflate state with stress responses (MES2 is explicitly hypoxia-linked, a possible dissociation artifact). What would falsify the model: subclones strictly mapping to single states, or failure of sorted single-state cells to regenerate multi-state tumors.

    Note: the second figure encodes qualitative association categories reported in the paper (all p-values stated as <10βˆ’5 or significant by hypergeometric test), not measured effect sizes.



    Feedback:    

    Updated: November 19, 2026

     BGPT Paper Review



    Study Novelty

    90%

    First unified framework resolving TCGA bulk subtypes into four plastic malignant cellular states with genetic determinantsβ€”a landmark conceptual advance for tumor heterogeneity.



    Scientific Quality

    90%

    Extensive orthogonal validation (ISH, cross-platform, PDX, barcoding, functional overexpression, TCGA). Weaknesses: CNA inference limits, MES state lacking amplification association, MES2/hypoxia confound, code only on request.



    Study Generality

    80%

    Framework explicitly generalizableβ€”adopted across gliomas and other cancers; some findings (barcoding plasticity) validated only in mouse/PDX models.



    Study Usefulness

    90%

    Became the field-standard state-scoring system; directly enabled drug-plasticity and state-selective-lethality therapeutic strategies in follow-up work.



    Study Reproducibility

    80%

    Public data (SCP393, GSE131928) and detailed STAR Methods; analysis code only on request, not repository-deposited.



    Explanatory Depth

    90%

    Provides a causal mechanistic model: genetic drivers set transition rates that yield steady-state distributions, unifying genetics, development, and microenvironment.


    🎁 Authors: Collect 500 Free Science Tokens (β‰ˆ $50.0 USD)

    Claim My Author Tokens

    Use for 125 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $50.0 USD)

     Top Data Sources ExportMCP



     Analysis Wizard



    Scoring GSE131928 glioblastoma single cells against the four Neftel meta-modules and testing whether EGFR amplification status predicts AC-like state frequency across tumors.



     Hypothesis Graveyard



    TCGA subtypes represent distinct genetic tumor lineagesβ€”falsified here: multiple subtypes coexist within single tumors and subclones span all four states.


    GSC markers (CD133, CD44, CD24) define distinct hierarchical stem-cell subtypesβ€”replaced by plastic state model; sorted fractions regenerate identical distributions.

     Science Art


    Paper Review: An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($64 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT